Table 2.
FDG SULmax and FLT SULmax values at all time points for each patient
| Patient number | Baseline | Post-cycle 1 | Post-cycle 2 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| FDG | FLT | CT | FDG | FLT | CT (%) | FDG | FLT | CT (%) | |
| 1 | 9.3 | 3.4 | 6.5 | 8.8 | 6.8 | 3.1 | 4.1 | 2.2 | −7.7 |
| 2* | 12.7 | 5.2 | 7.4 | 3.4 | 1.7 | −45.9 | 1.5 | 1.0 | −56.8 |
| 3 | 3.2 | 2.3 | 2.4 | 4.0 | 1.0 | 4.2 | 3.3 | 1.1 | −8.3 |
| 4 | 8.3 | 4.5 | 8.6 | 6.7 | 2.9 | 44.2 | – | 14.0 | −16.3 |
| 5 | 14.0 | 4.6 | 5.4 | 14.6 | 4.4 | 31.5 | 7.4 | 3.9 | −29.6 |
| 6* | 10.9 | 4.9 | 5.9 | 8.9 | 4.2 | −25.4 | 8.6 | 4.4 | −52.5 |
| 7 | 5.5 | 2.7 | 2.1 | 7.7 | 2.9 | 0.0 | 5.4 | 2.5 | −14.3 |
| 8 | 7.1 | 4.2 | 11.5 | 6.9 | 4.6 | −23.5 | 6.7 | 5.3 | −27.8 |
| 9* | 8.4 | 2.1 | 8.4 | 4.8 | 1.8 | −21.4 | 3.9 | 1.4 | −44.0 |
Post-cycle 1 and post-cycle 2 CT values are shown as percentage changes from baseline. Responders are denoted by an asterisk after the patient number